You are here: Home > Institute of Excellence (CPD) > CPD Events > EMERGING IOL TECHNOLOGY, SMILE WITH THE VISUMAX 800 & TRANS-EPITHELIAL CROSS-LINKING

EMERGING IOL TECHNOLOGY, SMILE WITH THE VISUMAX 800 & TRANS-EPITHELIAL CROSS-LINKING

Date: 11/10/2023 (AEDT)

Venue: 36 College Street, Darlinghurst, NSW, 2010

Provider: Vision Clinic Sydney

Contact: Amanda El-Akkad, [E] clinical@visionclinicsydney.com.au, [P] 9222 9188

Learning Objectives

  • Participants should be able to describe and understand the different types of intraocular lenses (IOLs) available in the market for cataract surgery and refractive lens exchange.
  • Participants should be able to stay up to date with emerging intraocular lens technologies and their potential benefits for patients.
  • Participants should be able to understand the role of corneal topography, pupillography and lens technology for identifying an appropriate IOL for cataract surgery or refractive lens exchange.
  • Participants should be able to evaluate the outcomes of SMILE surgery using the VisuMax 800 laser and compare them to other laser vision correction procedures, such as LASIK.
  • Participants should be able to define the benefits and features of SMILE laser surgery and the role of the VisuMax 800 laser in this procedure.
  • Participants understand the differences and benefits of transepithelial collagen cross-linking compared with Dresden protocol of cross-linking.
  • Participants should be able to revise the pathogenesis of glaucoma.
  • Participants should be able to identify and understand the visual field defects experienced by glaucoma sufferers.
  • Participants should be able to appreciate and understand the value of optical coherence tomography (OCT) in the diagnosis of glaucoma.

Max CPD hours awarded: 3

Session Information

Name
Emerging IOL technologies
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
1.25
Name
SMILE and the Visumax 800
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Transepithelial collagen cross-linking in keratoconus management
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Glaucoma - Pathogenesis, Visual Field Defects & The Role of OCT in Diagnosis
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.